Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
National
Henry Saker-Clark

GSK halts new clinical trials in Russia but continues supply of medicines

PA Archive

GlaxoSmithKline (GSK) has said it will keep supplying essential medicines in Russia but will halt new clinical trials due to the invasion of Ukraine.

The pharmaceutical giant confirmed it will not start clinical trials or enrol new patients in existing trials in Russia.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.